214 , 829835 (1993) Deacon, C
Scalability & User Capacity : For digital wellness platforms integrating GLP-1 solutions, ensure the supplier can support high-volume, on-demand fulfillment with API or ERP integration
More precisely, in early clinical trials, Retatrutide has shown the potential for significant weight loss, with participants on the highest dose losing an average of 28.7% of their body weight over 68 weeks, which is double the weight loss seen with other GLP-1 medications like Ozempic and Wegovy
The Boston Business Journal has more details here (heads up, there's a paywall)
It is important to recognize that natural methods to increase GLP-1 are complementary strategies, not replacements for evidence-based medical therapy when clinically indicated
Compounded semaglutide is considered an eligible medical expense when prescribed by a licensed provider for a diagnosed medical condition (obesity or type 2 diabetes)